Journal of Nanomaterials

Journal of Nanomaterials / 2016 / Article
Special Issue

Advances in Functionalized Materials Research 2016

View this Special Issue

Research Article | Open Access

Volume 2016 |Article ID 1062878 |

Cristina Liana Popa, Aurélien Deniaud, Isabelle Michaud-Soret, Régis Guégan, Mikael Motelica-Heino, Daniela Predoi, "Structural and Biological Assessment of Zinc Doped Hydroxyapatite Nanoparticles", Journal of Nanomaterials, vol. 2016, Article ID 1062878, 10 pages, 2016.

Structural and Biological Assessment of Zinc Doped Hydroxyapatite Nanoparticles

Academic Editor: Antonios Kelarakis
Received29 Mar 2016
Revised23 May 2016
Accepted01 Jun 2016
Published30 Jun 2016


The aim of the current research work was to study the physicochemical and biological properties of synthesized zinc doped hydroxyapatite (ZnHAp) nanoparticles with Zn concentrations (HAp), (7ZnHAp), and (10ZnHAp) for potential use in biological applications. The morphology, size, compositions, and incorporation of zinc into hydroxyapatite were characterized by scanning electron microscopy (SEM), transmission electron microscopy (TEM), Fourier Transform Infrared Spectroscopy (FTIR), Raman scattering, and X-Ray Photoelectron Spectroscopy (XPS). In addition, the cytotoxicity of ZnHAp nanoparticles was tested on both E. coli bacteria and human hepatocarcinoma cell line HepG2. The results showed that ZnHAp nanoparticles (HAp, 7ZnHAp, and 10ZnHAp) have slightly elongated morphologies with average diameters between 25 nm and 18 nm. On the other hand, a uniform and homogeneous distribution of the constituent elements (calcium, phosphorus, zinc, and oxygen) in the ZnHAp powder was noticed. Besides, FTIR and Raman analyses confirmed the proper hydroxyapatite structure of the synthesized ZnHAp nanoparticles with the signature of phosphate, carbonate, and hydroxyl groups. Moreover, it can be concluded that Zn doping at the tested concentrations is not inducing a specific prokaryote or eukaryote toxicity in HAp compounds.

1. Introduction

In recent decades, modern medicine rapidly has progressed. In particular, the fields of nanomedicine and tissue engineering have offered new and improved solutions to numerous health problems thus enhancing the quality of life of patients who suffer from various diseases. One of the medical fields that had gained from the development of nanomedicine is the orthopedic surgeries. Ceramic materials are in fact used nowadays either as coating materials for metal prosthesis or as scaffolds for tissue growth [1]. One of the most commonly used biomaterials is hydroxyapatite (HAp) due to its similarity with the main inorganic component of the human natural hard tissue [2]. The biocompatibility of HAp along with its bioactive properties has made it a good candidate for being used as a filling material for bone repair and bone replacement or as an osteoinductive and conductive coating [3]. When used as a coating material for metallic prosthesis, HAp forms physicochemical bonds with the surrounding bone tissue thus promoting bone formation which is essential for the osseointegration of the implant [4, 5]. To further improve physicochemical and mechanical properties of HAp, researchers have focused their efforts in modifying its structure by doping it with different metallic ions [6]. It was observed that doping HAp with different metallic ions led to changes of the lattice parameters, crystallinity, and other physical properties of the HAp [4, 7]. One of the trace elements that has an essential role in the human bone and plasma is zinc [8]. Being a cofactor in more than 300 enzymes and contributing to the metabolism of proteins, carbohydrates, and lipids [9], zinc has a catalytic, structural, and regulatory role in the human body [9]. Almost 30% of the total amount of zinc found in the human body is located in the bone tissue, a lack of it inducing serious health problems such as growth retardation, male hypogonadism, or abnormal neurosensory changes [912]. Additionally, zinc deficiency induces delayed wound healing, anorexia, weight loss, and an increased susceptibility to infections [912]. Therefore, doping HAp with Zn2+ ions offers the opportunity of obtaining an improved biocomposite with enhanced physicochemical properties. Such a material could be used in the future as a coating material for improved prosthesis, reducing the risk of implant rejection by the human body and at the same time improving the quality of life of patients suffering from orthopedic surgeries. In order to synthesize hydroxyapatite with controlled and uniform particle size, various methods such as sol-gel [4], wet-chemical [3], or coprecipitation [12] have been used. The synthesis method that we present in this study provides new information on synthesis parameters and has the potential to be used for synthesis of novel nanostructures. On the other hand, to the best of our knowledge, there are no reliable studies previously reported on the cytotoxicity observed for both E. coli and HepG2 cells. Furthermore, until now, eloquent studies regarding the influence of particle size on cytotoxicity are not presented.

Thus, the aim of this study was to prepare zinc doped hydroxyapatite (HAp, 7ZnHAp, and 10ZnHAp) nanoparticles for future use in possible biological applications. To this end, the cytotoxicity and the antibacterial activity of ZnHAp were also evaluated.

2. Materials and Methods

2.1. Materials

In order to synthesize the zinc doped hydroxyapatite (ZnHAp), precursors of calcium nitrate [Ca(NO3)2·4H2O, 99% purity, Aldrich, USA], ammonium hydrogen phosphate ((NH4)2HPO4; Wako Pure Chemical Industries Ltd.), and Zn(NO3)6·6H2O (Alpha Aesare, Germany, 99.99% purity) were used.

2.2. Preparation of Zinc Doped Hydroxyapatite (ZnHAp) Nanoparticles

ZnHAp was synthetized by a modified coprecipitation method [13]. ZnHAp samples, Ca10−x Znx(PO4)6(OH)2, with , 0.07, and 0.1, respectively, were synthesized in air at a temperature of 80°C using aqueous solutions with various Zn : (Zn + Ca) ion ratios, the [Ca + Zn]/P ratio being maintained at 1.67 [13, 14]. Appropriate amounts of Ca(NO3)2·4H2O and Zn(NO3)2·6H2O were dissolved in deionized water. The pH value of the suspension was adjusted to 10 adding 28% ammonia solution. A phosphate solution was prepared by dissolving (NH4)2HPO4 in deionized water. The (NH4)2HPO4 solution was added to the Ca(NO3)2·4H2O/Zn(NO3)2·6H2O solution at room temperature under constant stirring for 72 h at 80°C. The resulting precipitate was filtered, washed five times with deionized water, and centrifuged. Finally, the obtained ZnHAp precipitates were dried in an oven at 80°C for 72 hours.

2.3. Structural and Morphological Examination

The crystal phase was determined by powder X-ray diffraction (XRD) measurements using a Bruker D8 Advance diffractometer, with nickel filtered CuKα ( Å) radiation and a high efficiency one-dimensional detector (Lynx Eye type) operated in integration mode. The samples were scanned in the 2θ range 20°–80°, with a step of 0.02° and 34 s measuring time per step.

The morphology, crystalline structure, and size of ZnHAp nanoparticles were examined by TEM and SEM. For TEM observations, the instrument was Tecnai 120 keV from FEI. Classic modes such bright field (BF) to image the texture of the materials (shape, dimension) and Selected Area Diffraction (SAD) to precise the structure were used. Grain size distribution was determined by measuring the mean diameter, of about 500 particles on the TEM micrographs. For SEM examinations, a Quanta Inspect F scanning electron microscope equipped with an energy dispersive X-ray (EDX) attachment was used.

2.4. Fourier Transform Infrared Spectroscopy

In order to study the structure of the prepared samples, FTIR measurements were performed. The functional groups present in each sample were identified with a Spectrum BX Spectrometer. 1% of each zinc doped hydroxyapatite powder with , 0.07, and 0.1 was mixed and ground with 99% KBr. The mixture was afterwards pressed at a load of 5 tons for 2 min, resulting in 10 mm diameter pellets. Each KBr-ZnHAp disc was scanned over a wavenumber range between 400 and 4000 cm−1, with a resolution of 4 and 128 times scanning.

2.5. Raman Spectroscopy

Complementary to FTIR measurements, Raman spectroscopy measurements were performed using a RenishawInVia dispersive Raman spectrometer (2012), equipped with a Leica DM microscope and one laser source at 514 nm (gas-type), Spectra Physics Ar ion laser (20 mW). The spectra were acquired using the 514 nm laser with a power of 0.2 mW and 1800 L/mm gratings. All the spectra were registered in the 350–1200 cm−1 spectral range with a resolution below 2 cm−1. Before each measurement, the instrument was calibrated on the internal Si-reference standard (520.6 ± 0.1 cm−1).

2.6. X-Ray Photoelectron Spectroscopy

XPS measurements were performed with a SPECS Multimethod Surface Analysis System using monochromatic Al Kα radiation (1486.6 eV). In the analyzer chamber, the vacuum was ~ 3 × 10−9 torr. The X-rays are emitted by an Al anticathode with  kV and a filament emission current  mA. For charge compensation, a FG40 flood gun was used. The provided electron beam had 2 eV and 0.3 mA. The XPS recorded spectrum involved an energy window  eV with the resolution  eV and with 400 recording channels. The XPS spectra recorded were processed using Spectral Data Processor v2.3 (SDP) software.

2.7. Laser Ablation-Inductively Coupled Plasma-Mass Spectrometer (LA-ICP-MS) Analysis

Laser ablation-inductively coupled plasma-mass spectrometer (LA-ICP-MS) analysis was performed on the samples. An elemental XR Thermo Specific, following the procedure described by Motelica-Heino and Donard [15], was used in combination with a VG UV laser probe laser ablation sampling device. Solid samples were prepared as pressed pellets. The repetition rate of the 266 nm wavelength laser was fixed to 10 Hz. Calibration was performed with certified artificial glass, NIST-610. Measurements were replicated four times to validate the analytical precision of the technique.

2.8. Cytotoxicity Assays

The ZnHAp compounds were dispersed in water to a final concentration of 10 mg/mL.

2.9. HepG2 Cell Viability Assays

HepG2 cell growth assays were performed as previously described [16] with the following modifications: HepG2 cells were grown in Minimum Essential Medium (MEM) supplemented with 10% v/v fetal bovine serum (FBS), 20 mM L-glutamine, 100 μg·mL−1 streptomycin, and 100 U mL−1 penicillin. Cells were cultured at 37°C in a humidified atmosphere with 5% CO2.

For cell viability assays, HepG2 cells were seeded in each well of 12-well plates. On the following day, ZnHAp were added at 0, 62.5, 125, 250, 500, and 1000 μg/mL for 24 h. Cells were rinsed twice with PBS, harvested using trypsin, and suspended in 200 μL PBS. Cell viability was determined by counting Trypan Blue stained cells in a TC20 Automated Cell Counter (Bio-Rad).

2.10. Antibacterial Activity Assay

The quantitative assay of the minimal inhibitory concentration (MIC, μg/mL) was based on twofold serial dilutions performed in 96-well plates. For this purpose, serial dilutions of the tested compounds (ranging between 1000 and 1.95 μg/mL) were performed to final volumes of 400 μL in Luria Bertani medium. Each well was inoculated with the E. coli MG1655 strain at a 600 nm absorbance of 0.02. The initial absorbance was measured in a Tecan plate reader. The culture was then performed in deep well plates incubated at 30°C with constant shaking of 280 rpm and the final absorbance at 600 nm was measured after 12 hours.

3. Results and Discussions

The X-ray diffraction patterns of hydroxyapatite doped with Zn (HAp, 7ZnHAp, and 10ZnHAp) are presented in Figure 1. The unique phase was found to be hexagonal hydroxyapatite (standard card ICDD-PDF number 9-432). The width of the diffraction peaks may be due to decrease of particle size and decrease of the apatite crystallinity. Previous results presented by Miyaji et al. [17] revealed that the width of the diffraction peaks suggests that the crystallinity of the apatite significantly decreases with the increase of zinc concentration. The unit cell parameters of ZnHAp were determined by Rietveld refinement of XRD data collected over 2θ range 20–80° using MAUD software [18].

The values of lattice parameters “a” and “c” decreased when the Zn concentration in the samples increased. On the other hand, the average crystallite size decreases with Zn substitutions, from 23.1879 nm (HAp) to 19.385 nm (7ZnHAp) and 15.8763 nm (10ZnHAp). The results presented in this study are logical and in agreement with those previously presented by Thian et al. [19], since the ionic radius of Zn2+ (0.074 nm) is smaller in size than Ca2+ (0.099 nm).

The morphology and elemental composition of ZnHAp samples were examined by scanning electron microscopy (SEM). The obtained results are presented in Figures 2 and 3. The SEM micrographs (Figure 2) revealed that the morphology of the powders is slightly influenced by the increasing quantity of Zn in the powders. It could be observed that the powders are consisting of nanoparticles with elongated morphology. Also, in the SEM images it could be noticed that the nanoparticles tend to agglomerate due to their nanometric dimensions. The micrographs confirmed the fact that increasing the Zn content leads to a decrease of the nanoparticles dimensions. EDX spectra of 10ZnHAp samples were acquired (Figure 3). The EDX spectrum confirmed only the presence of the calcium, phosphorus, zinc, and oxygen. On the other hand, the ICP-MS study was performed to investigate the quantities of zinc in the 7ZnHAp and 10ZnHAp powders. The concentration of zinc increases from 13.77 mg/g (7ZnHAp) to 14.36 mg/g (10ZnHAp). Our present results are in good agreement with the previous studied performed by Ewald et al. [20].

In Figure 3 the elemental mapping results obtained for the 10ZnHAp powder are presented. The results showed that the powder is composed of calcium, phosphorus, zinc, and oxygen, the main chemical elements of the ZnHAp structure. Also, the uniform and homogeneous distribution of these elements in the powder could be noticed. Moreover, there was no evidence of any impurities in the sample. The obtained results confirm the presence of Zn in the powder and its homogeneous distribution through the sample.

The TEM micrographs (Figure 4) revealed information about the texture of the materials (shape, dimension). In order to present the structural evolution of the material containing different concentrations of zinc, the SAD image was inserted. The size distribution is also presented in Figure 3. It could be observed that all the powders (HAp, 7ZnHAp, and 10ZnHAp) are consisting of nanoparticles with a slightly elongated morphology and a mean diameter between 25 nm and 16 nm. The agglomeration of the nanoparticles was also noticed. A decrease of the nanoparticles size was observed when the concentrations of zinc increased. The SAD analysis confirmed the formation of hydroxyapatite characteristic hexagonal structure.

In order to highlight the functional groups of the studied samples, FTIR and Raman measurements were performed. The FTIR spectra acquired for the HAp, 7ZnHAp, and 10ZnHAp samples are presented in Figure 5. On the right bottom side of each spectrum the spectral region between 1600 cm−1 and 4000 cm−1 characteristic of the water lattice is presented.

All the bands found in the three spectra are associated with phosphate, carbonate, and hydroxyl groups and are characteristic of the hydroxyapatite structure. The great majority of the vibrational bands evidenced through FTIR measurements could be attributed to different vibrational modes of the functional group. In this context, the symmetric and antisymmetric stretching modes of the phosphate group were highlighted by the following bands: the band from 962 cm−1 is attributed to the symmetric stretching mode [21, 22], while the band from 1096 cm−1 is attributed to the asymmetric stretching mode [23]. On the other hand, the bending modes of the phosphate group are evidenced by the bands from 566 cm−1 and 602 cm−1, respectively. Both of them are attributed to the mode [21, 24, 25]. Furthermore, the band from around 1036 cm−1 is associated with the bending mode [21, 26]. There is also another band attributed to the found in the spectral range 870–880 cm−1 [21, 24]. However, this one is almost impossible to distinguish due to the fact that it overlaps another vibrational band attributed to the group [26]. The carbonate functional group could be also evidenced by the bands from 1414–1450 cm−1 spectral range [27]. These bands describe the C-O vibrations and their presence suggests that, during the low temperature synthesis, a certain amount of carbonate was incorporated in the samples [27]. The vibrational mode of the hydroxyl group is evidenced by the band from around 630 cm−1, while the stretching mode of the same functional group is evidenced by the band from around 3572 cm−1 [21, 25, 28]. Generally, the adsorbed water molecules present in the hydroxyapatite structure are described by the vibrational bands from around 1630 cm−1 [21, 29] and those from the 3000–3800 cm−1 [25] spectral region. The general behavior of the FTIR spectra exhibits a widening of the peaks and an overall smoothing when the Zn concentration from the samples increases. This behavior suggests a decrease of the crystallinity of the samples with the increase of zinc concentration.

As for FTIR results, all the peaks presented in the Raman spectra are associated with the functional groups characteristic of hydroxyapatite (Figure 6).

They are all attributed to different stretching and bending modes of the phosphate groups. The totally symmetric stretching mode of the P-O bond is described by the presence of the very sharp band from 961 cm−1, while the triply degenerated asymmetric stretching mode of the same P-O bond is evidenced by the peaks at 1046 cm−1 [21, 30] and 1074 cm−1 [31], respectively. On the other hand, the bands at 433 cm−1 and 448 cm−1 are attributed to the double degenerated bending mode of the phosphate group [21, 30, 31], while the bands at 580 cm−1, 607 cm−1, and 590 cm−1 [31] are associated with the triple degenerated bending mode. All the mentioned vibrational peaks which describe the bending modes of the functional group describe the vibrations of the O-P-O bonds [21, 30, 31].

Although all these Raman bands are present in the three spectra, it is interesting to note that their intensities gradually decrease as Zn concentration in the samples increases.

The XPS general spectra for the 7ZnHAp and 10ZnHAp samples, after the powders were dried at 40°C, are presented in Figures 7(a)-7(b). Figure 6 revealed the presence of Ca 2p, P 2p, O 1s, and Zn 2p elements in the XPS spectra of the ZnHAp samples with and .

The C 1s peak that can be seen at a binding energy () of 284 eV is due to the adsorbed carbon. The photoelectron peak for O 1s can be observed at  eV and P 2p at around 133 eV. The spectra of Ca 2p, P 2p, and Zn 2p are also presented in Figure 7(b). The XPS spectral peaks for Ca 2p in the ZnHAp powders are assigned to the 2p3/2 electronic states of Ca(II). In the 10ZnHAp sample two peaks were observed at 347, 27 and 350, 76 eV. In previous studies on “chemical analysis of silica doped hydroxyapatite biomaterials consolidated by a spark plasma sintering method,” Xu and Khor [32] showed that the calcium atoms are related with a phosphate group (). The spectrum of P 2p is composed of two components that were identified at around 133.09 eV and 133.78 eV. The “XPS study of apatite-based coatings prepared by sol-gel technique” conducted by Kačiulis et al. [33] showed that these two values of binding energy obtained for P 2p spectrum are characteristic of HAp. XPS characterizations of ZnHAp powders revealed that the Zn 2p spectrum exhibits two peaks. The two Zn related peaks of the 10ZnHAp sample can be observed at 1022 eV and 1023, 95 eV. According to the studies conducted by Zhang et al. [34] these two peaks can be attributed to the 2p3/2 and 2p1/2 electronic states of Zn(II).

In the last decade, increased efforts have been directed to promoting the use of nanoparticles in different biomedical applications including nanomedicine. In this research study, the cytotoxicity of the three compounds HAp, 7ZnHAp, and 10ZnHAp has been tested both on the E. coli bacteria and on the human hepatocarcinoma cell line HepG2.

The biocidal effects for three different samples are quite similar with a growth inhibition starting at 250 μg/mL and a significant growth inhibition observed at 500 and 1000 μg/mL (Figure 7(a)). The similarity between HAp, 7ZnHAp, and 10ZnHAp showed that this low toxicity is not related to the presence of zinc but is most probably due to a mechanical effect on the bacteria induced by the large particles present in solution. This hypothesis is strengthened by the slightly lower toxicity observed with 10ZnHAp that contains more Zn but forms smaller particles.

Interestingly, HepG2 cell viability is only moderately affected by 7ZnHAp and 10ZnHAp with a cell death around 20% for all tested conditions but the control (Figure 8(b)). HAp induced a slightly higher cell death than ZnHAp at 62.5, 125, and 250 μg/mL in a dose-dependent manner reaching 40% mortality. The toxicity is then decreasing for the higher concentrations 500 and 1000 μg/mL reaching only 20% cell death (Figure 8(b)), a similar level to the ZnHAp. However, HAp and the ZnHAp have a particulate nature in the culture media that can lead to a decrease of the overall cell count per sample for the higher concentrations. This is not negligible for HAp that forms the larger particle. Therefore, the higher survival at 500 and 1000 μg/mL of HAp is probably overestimated.

Altogether, one can conclude that Zn doping at the tested concentrations is not inducing a specific prokaryote or eukaryote toxicity in HAp compounds. The cytotoxicity observed for both E. coli and HepG2 cells is most probably due to deleterious interactions between the large particles formed by the HAp and ZnHAp and cell membranes. Indeed, HAp that formed the larger particles induce the highest lethality in the different experiments performed in this study.

This study clearly revealed that the activity of ZnHAp nanoparticles against HepG2 cells was significantly dependent on the particle size. In agreement with our results, the existing studies in the literature [35, 36] have shown that the cytotoxicity of ZnHAp nanoparticles against HepG2 cells is dependent on their size. The increase of the zinc concentration in the HAp structure led to a decrease of the particle size. Therefore, the particle size decreases as the percentage of the dopant (zinc) increases. Also, Chithrani et al. [37] reported in their studies that the cellular uptake kinetics and saturation concentrations are highly dependent upon the physical dimensions of the nanoparticles. On the other hand, Osaki et al. [38] established that semiconductor nanoparticles with a diameter of 50 nm penetrated into cells via receptor-mediated endocytosis more easily than smaller nanoparticles.

Recently, the studies concerning the correlation between particle properties and their cytotoxicity and biostability [39] showed that, regarding the cellular uptake, rod-shaped hydroxyapatite nanoparticles have a considerable advantage compared to spherical nanoparticles.

The goal of research aimed at orthopedic and dental fields is to produce high quality materials for bone substitutions, which are also able to repair or replace bone tissue. It is known that infections affect the regeneration ability of tissues. Also, Romanò et al. [40] showed that infections that may occur in time determine a major limitation to long-term utility of medical implants. Recently it was shown that the nanoparticles represent a feasible alternative for the treatment of various diseases because of their unique biological effect caused by their new properties determined by morphology, size, and surface at nanoscale.

In this study, we prepared zinc doped hydroxyapatite nanoparticles with elongated morphology and a mean diameter between 25 nm and 16 nm. Structural analysis confirmed the homogeneous distribution of Zn in the powders and the formation of hydroxyapatite characteristic hexagonal structure. Furthermore, the biological investigations suggested that the cytotoxicity of the studied samples on both E. coli and HepG2 cells depends on the particle size. Based on previous studies which showed that metal ions released from metal oxide nanoparticles contribute to the cytotoxicity of the compounds [41], Venkatasubbu et al. [35] established that the release of Ca2+ and Zn2+ ions from pure hydroxyapatite and zinc doped hydroxyapatite is responsible for the cytotoxicity. On the other hand, recent studies [35] proved that the cytotoxic and genotoxic mechanisms of HAp and zinc doped HAp are related to their membrane penetration capability and their apoptosis activity. In addition, recent studies showed that M. luteus, a Gram-positive bacteria, commonly found in mucous membranes, was highly inhibited by nano-HAp and doped nano-ZnHAp [42]. On the other hand, Huang et al. [43] showed in their study on “anticorrosive effects and in vitro cytocompatibility of calcium silicate/zinc doped hydroxyapatite composite coatings on titanium” that the high cytocompatibility of calcium silicate/zinc doped hydroxyapatite could be mainly attributed to the combination of microporous surface effects and ion release (Zn2+ and Si4+). The Zn-Ag-HAp nanoparticles were found to be compatible with in vitro experiments and having potential antibacterial properties and could be a promising candidate for future biomedical applications [44]. In addition, the cell response tests, conducted by Ding et al. [45], established that MC3T3-E1 cells on ZnHAp coating clearly enhanced the in vitro cytocompatibility of Ti compared with HAp coating. Moreover, Venkatasubbu et al. [35] demonstrated that specific physicochemical properties of nanoparticles can alter their assimilation ability. In accordance with our results, they showed that the concentration and size of the nanoparticles are very important in the assimilation of the substance. Finally, we might conclude that controlled physical and chemical properties of nanoparticles play an important role in the cell absorption.

4. Conclusions

In this study the morphological, structural, and biological properties of zinc doped hydroxyapatite nanopowders were analyzed. For this purpose, samples with various zinc concentrations (HAp, 7ZnHAp, and 10ZnHAp) were synthesized. The SEM micrographs revealed a decrease of the particles size when the zinc concentration from the samples increased. These findings were also supported by TEM images. Furthermore, the size distribution showed that the nanoparticle diameters vary between 19 nm and 25 nm. Also, the SAED investigation revealed the formation of the hydroxyapatite characteristic hexagonal structure.

However, both FTIR and Raman spectra of all three samples revealed a decrease of the peak intensities when the zinc concentration increased. This behavior suggests a decrease of the sample crystallinities with the increase of zinc content. On the other hand, the presence of the hydroxyapatite characteristic structure was also supported by XPS spectra obtained for the two zinc doped hydroxyapatite samples with and , respectively.

Lastly, biological investigations were performed for the three samples (HAp, 7ZnHAp, and 10ZnHAp) both on the E. coli bacteria and on the human hepatocarcinoma cell line HepG2. The results suggested that the cytotoxicity of the studied samples on both E. coli and HepG2 cells depends on the particle size. Considering that the size of the nanoparticles decreased when the zinc concentration from the samples increased, the highest death rate of the cells was achieved for the HAp sample, while the lowest death rate was achieved for the 10ZnHAp sample.

Our research proved that the new adapted coprecipitation method is a time and cost efficient synthesis method for obtaining zinc doped hydroxyapatite nanoparticles with promising properties for various biomedical applications. It can be concluded that the results presented in this paper form the premises for future studies on high quality materials that could be used eventually in various biomedical applications.

Competing Interests

The authors report no conflict of interests in this work.


The authors are grateful to Dr. Catalin Constantin Negrila for XPS measurements. This work was supported by the IFA-CEA C4-05/2014 project and Core Program PN 16-48/2016 (MS-FISCOMAT).


  1. M. H. Santos, L. G. Dias Heneine, and H. S. Mansur, “Synthesis and characterization of calcium phosphate/collagen biocomposites doped with Zn2+,” Materials Science and Engineering C, vol. 28, no. 4, pp. 563–571, 2008. View at: Publisher Site | Google Scholar
  2. Y. Tang, H. F. Chappell, M. T. Dove, R. J. Reeder, and Y. J. Lee, “Zinc incorporation into hydroxylapatite,” Biomaterials, vol. 30, no. 15, pp. 2864–2872, 2009. View at: Publisher Site | Google Scholar
  3. F. Ren, R. Xin, X. Ge, and Y. Leng, “Characterization and structural analysis of zinc-substituted hydroxyapatites,” Acta Biomaterialia, vol. 5, no. 8, pp. 3141–3149, 2009. View at: Publisher Site | Google Scholar
  4. E. Jallot, J. M. Nedelec, A. S. Grimault et al., “STEM and EDXS characterisation of physico-chemical reactions at the periphery of sol-gel derived Zn-substituted hydroxyapatites during interactions with biological fluids,” Colloids and Surfaces B: Biointerfaces, vol. 42, no. 3-4, pp. 205–210, 2005. View at: Publisher Site | Google Scholar
  5. S. Raita, N. Cornila, V. Danacu et al., “Morphological studies on the liver in Struthio camelus,” Anatomia Histologya Embryologya, vol. 43, no. 1, pp. 74–75, 2014. View at: Google Scholar
  6. C. S. Ciobanu, A. Groza, S. L. Iconaru et al., “Antimicrobial activity evaluation on silver doped hydroxyapatite/polydimethylsiloxane composite layer,” BioMed Research International, vol. 2015, Article ID 926513, 13 pages, 2015. View at: Publisher Site | Google Scholar
  7. G. Daculsi, R. Z. LeGeros, M. Heughebaert, and I. Barbieux, “Formation of carbonate-apatite crystals after implantation of calcium phosphate ceramics,” Calcified Tissue International, vol. 46, no. 1, pp. 20–27, 1990. View at: Publisher Site | Google Scholar
  8. E. Fujii, M. Ohkubo, K. Tsuru et al., “Selective protein adsorption property and characterization of nano-crystalline zinc-containing hydroxyapatite,” Acta Biomaterialia, vol. 2, no. 1, pp. 69–74, 2006. View at: Publisher Site | Google Scholar
  9. C. O. Molokwu and Y. V. Li, “Zinc homeostasis and bone mineral density,” Ohio Research and Clinical Review, vol. 15, pp. 6–15, 2006. View at: Google Scholar
  10. R. Tudor, P. D. Zalewski, and R. N. Ratnaike, “Zinc in health and chronic disease,” Journal of Nutrition, Health and Aging, vol. 9, no. 1, pp. 45–51, 2005. View at: Google Scholar
  11. V. Danacu, S. Raita, and C. Ionita, “Morphological studies on visceral lymph nodes of the abdominal cavity in the rabbit,” Anatomia Histologya Embryologya, vol. 43, no. 1, pp. 34–35, 2014. View at: Google Scholar
  12. C. S. Ciobanu, F. Massuyeau, L. V. Constantin et al., “Structural and physical properties of antibacterial Ag-doped nano-hydroxyapatite synthesized at 100°C,” Nanoscale Letters, vol. 6, no. 1, pp. 613–620, 2011. View at: Google Scholar
  13. C. S. Ciobanu, S. L. Iconaru, F. Massuyeau, L. V. Constantin, A. Costescu, and D. Predoi, “Synthesis, structure, and luminescent properties of europium-doped hydroxyapatite nanocrystalline powders,” Journal of Nanomaterials, vol. 2012, Article ID 942801, 9 pages, 2012. View at: Publisher Site | Google Scholar
  14. C. S. Ciobanu, C. L. Popa, and D. Predoi, “Sm:HAp nanopowders present antibacterial activity against Enterococcus faecalis,” Journal of Nanomaterials, vol. 2014, Article ID 780686, 9 pages, 2014. View at: Publisher Site | Google Scholar
  15. M. Motelica-Heino and O. F. X. Donard, “Comparison of UV and IR laser ablation ICP-MS on silicate reference materials and implementation of normalisation factors for quantitative measurements,” Geostandards Newsletter, vol. 25, no. 2-3, pp. 345–359, 2001. View at: Publisher Site | Google Scholar
  16. M. Cuillel, M. Chevallet, P. Charbonnier et al., “Interference of CuO nanoparticles with metal homeostasis in hepatocytes under sub-toxic conditions,” Nanoscale, vol. 6, no. 3, pp. 1707–1715, 2014. View at: Publisher Site | Google Scholar
  17. F. Miyaji, Y. Kono, and Y. Suyama, “Formation and structure of zinc-substituted calcium hydroxyapatite,” Materials Research Bulletin, vol. 40, no. 2, pp. 209–220, 2005. View at: Publisher Site | Google Scholar
  18. L. Lutterotti, “Total pattern fitting for the combined size-strain-stress-texture determination in thin film diffraction,” Nuclear Instruments and Methods in Physics Research, Section B: Beam Interactions with Materials and Atoms, vol. 268, no. 3-4, pp. 334–340, 2010. View at: Publisher Site | Google Scholar
  19. E. S. Thian, T. Konishi, Y. Kawanobe et al., “Zinc-substituted hydroxyapatite: a biomaterial with enhanced bioactivity and antibacterial properties,” Journal of Materials Science: Materials in Medicine, vol. 24, no. 2, pp. 437–445, 2013. View at: Publisher Site | Google Scholar
  20. A. Ewald, D. Hösel, S. Patel, L. M. Grover, J. E. Barralet, and U. Gbureck, “Silver-doped calcium phosphate cements with antimicrobial activity,” Acta Biomaterialia, vol. 7, no. 11, pp. 4064–4070, 2011. View at: Publisher Site | Google Scholar
  21. S. Koutsopoulos, “Synthesis and characterization of hydroxyapatite crystals: a review study on the analytical methods,” Journal of Biomedical Materials Research, vol. 62, no. 4, pp. 600–612, 2002. View at: Publisher Site | Google Scholar
  22. C. B. Baddiel and E. E. Berry, “Spectra-structure correlations in hydroxyapatite and fluorapatite,” Spectrochimica Acta A, vol. 22, pp. 1407–1416, 1966. View at: Google Scholar
  23. I. Rehman and W. Bonfield, “Characterization of hydroxyapatite and carbonated apatite by photo acoustic FTIR spectroscopy,” Journal of Materials Science: Materials in Medicine, vol. 8, no. 1, pp. 1–4, 1997. View at: Publisher Site | Google Scholar
  24. K. P. Tank, P. Sharma, D. K. Kanchan, and M. J. Joshi, “FTIR, powder XRD, TEM and dielectric studies of pure and zinc doped nano-hydroxyapatite,” Crystal Research and Technology, vol. 46, no. 12, pp. 1309–1316, 2011. View at: Publisher Site | Google Scholar
  25. S. J. Joris and C. H. Amberg, “The nature of deficiency in nonstoichiometric hydroxyapatites. II. Spectroscopic studies of calcium and strontium hydroxyapatites,” Journal of Physical Chemistry, vol. 75, no. 20, pp. 3172–3178, 1971. View at: Publisher Site | Google Scholar
  26. L. Berzina-Cimdina and N. Borodajenko, “Research of calcium phosphates using fourier transform infrared spectroscopy,” in Infrared Spectroscopy—Materials Science, Engineering and Technology, T. Theophanides, Ed., InTech, 2012. View at: Google Scholar
  27. I. R. de Lima, A. M. Costa, I. N. Bastos, J. M. Granjeiro, and G. D. A. Soares, “Development and characterization of 5% mol Zn bioceramic in granular form,” Materials Research, vol. 9, no. 4, pp. 399–403, 2006. View at: Google Scholar
  28. J. Arends, J. Christoffersen, M. R. Christoffersen et al., “A calcium hydroxyapatite precipitated from an aqueous solution: an international multimethod analysis,” Journal of Crystal Growth, vol. 84, no. 3, pp. 515–532, 1987. View at: Publisher Site | Google Scholar
  29. R. Z. LeGeros, “The unit-cell dimensions of human enamel apatite: effect of chloride incorporation,” Archives of Oral Biology, vol. 20, no. 1, pp. 63–71, 1975. View at: Publisher Site | Google Scholar
  30. G. R. Sauer, W. B. Zunic, J. R. Durig, and R. E. Wuthier, “Fourier transform raman spectroscopy of synthetic and biological calcium phosphates,” Calcified Tissue International, vol. 54, no. 5, pp. 414–420, 1994. View at: Publisher Site | Google Scholar
  31. P. N. de Aza, F. Guitian, and C. Santos, “Vibrational investigation of calcium phosphate compounds. 2. Comparison between hydroxyapatite and -tricalcium phosphate,” Chemistry of Materials, vol. 9, no. 4, pp. 916–922, 1997. View at: Publisher Site | Google Scholar
  32. J. L. Xu and K. A. Khor, “Chemical analysis of silica doped hydroxyapatite biomaterials consolidated by a spark plasma sintering method,” Journal of Inorganic Biochemistry, vol. 101, no. 2, pp. 187–195, 2007. View at: Publisher Site | Google Scholar
  33. S. Kačiulis, G. Mattogno, L. Pandolfi, M. Cavalli, G. Gnappi, and A. Montenero, “XPS study of apatite-based coatings prepared by sol-gel technique,” Applied Surface Science, vol. 151, no. 1, pp. 1–5, 1999. View at: Publisher Site | Google Scholar
  34. H. Zhang, Y. Liang, X. Wu, and H. Zheng, “Enhanced photocatalytic activity of (Zn, N)-codoped TiO2 nanoparticles,” Materials Research Bulletin, vol. 47, no. 9, pp. 2188–2192, 2012. View at: Publisher Site | Google Scholar
  35. G. D. Venkatasubbu, S. Ramasamy, G. S. Avadhani, L. Palanikumar, and J. Kumar, “Size-mediated cytotoxicity of nanocrystalline titanium dioxide, pure and zinc-doped hydroxyapatite nanoparticles in human hepatoma cells,” Journal of Nanoparticle Research, vol. 14, article 819, 2012. View at: Publisher Site | Google Scholar
  36. W. Jiang, B. Y. S. Kim, J. T. Rutka, and W. C. W. Chan, “Nanoparticle-mediated cellular response is size-dependent,” Nature Nanotechnology, vol. 3, no. 3, pp. 145–150, 2008. View at: Publisher Site | Google Scholar
  37. B. D. Chithrani, A. A. Ghazani, and W. C. W. Chan, “Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells,” Nano Letters, vol. 6, no. 4, pp. 662–668, 2006. View at: Publisher Site | Google Scholar
  38. F. Osaki, T. Kanamori, S. Sando, T. Sera, and Y. Aoyama, “A quantum dot conjugated sugar ball and its cellular uptake. On the size effects of endocytosis in the subviral region,” Journal of the American Chemical Society, vol. 126, no. 21, pp. 6520–6521, 2004. View at: Publisher Site | Google Scholar
  39. M. Motskin, D. M. Wright, K. Muller et al., “Hydroxyapatite nano and microparticles: correlation of particle properties with cytotoxicity and biostability,” Biomaterials, vol. 30, no. 19, pp. 3307–3317, 2009. View at: Publisher Site | Google Scholar
  40. C. L. Romanò, M. Toscano, D. Romanò, and L. Drago, “Antibiofilm agents and implant-related infections in orthopaedics: where are we?” Journal of Chemotherapy, vol. 25, no. 2, pp. 65–80, 2013. View at: Publisher Site | Google Scholar
  41. K. Subramani, H. Hosseinkhani, A. Khraisat, M. Hosseinkhani, and Y. Pathak, “Targeting nanoparticles as drug delivery systems for cancer treatment,” Current Nanoscience, vol. 5, no. 2, pp. 135–140, 2009. View at: Publisher Site | Google Scholar
  42. K. P. Tank, K. S. Chudasama, V. S. Thaker, and M. J. Joshi, “Pure and zinc doped nano-hydroxyapatite: synthesis, characterization, antimicrobial and hemolytic studies,” Journal of Crystal Growth, vol. 401, pp. 474–479, 2014. View at: Publisher Site | Google Scholar
  43. Y. Huang, H. Zhang, H. Qiao et al., “Anticorrosive effects and in vitro cytocompatibility of calcium silicate/zinc-doped hydroxyapatite composite coatings on titanium,” Applied Surface Science, vol. 357, pp. 1776–1784, 2015. View at: Publisher Site | Google Scholar
  44. N. Iqbal, M. R. A. Kadir, N. H. Mahmood et al., “Characterization, antibacterial and in vitro compatibility of zinc-silver doped hydroxyapatite nanoparticles prepared through microwave synthesis,” Ceramics International, vol. 40, no. 3, pp. 4507–4513, 2014. View at: Publisher Site | Google Scholar
  45. Q. Ding, X. Zhang, Y. Huang, Y. Yan, and X. Pang, “In vitro cytocompatibility and corrosion resistance of zinc-doped hydroxyapatite coatings on a titanium substrate,” Journal of Materials Science, vol. 50, no. 1, pp. 189–202, 2015. View at: Publisher Site | Google Scholar

Copyright © 2016 Cristina Liana Popa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

2971 Views | 1343 Downloads | 23 Citations
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.